User profiles for Mihkel Plaas
 | Mihkel PlaasENT consultant Verified email at kliinikum.ee Cited by 41 |
Bovine colostrum-derived antibodies against SARS-CoV-2 show great potential to serve as prophylactic agents
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to impose a serious
burden on health systems globally. Despite worldwide vaccination, social distancing and …
burden on health systems globally. Despite worldwide vaccination, social distancing and …
Early intervention and lifelong treatment with GLP1 receptor agonist liraglutide in a Wolfram syndrome rat model with an emphasis on visual neurodegeneration …
… MP (Mihkel Plaas) performed hearing evaluation data analysis and interpretation. KS …
TJ and MP (Mario Plaas) performed electron microscopy on optic nerves and corresponding …
TJ and MP (Mario Plaas) performed electron microscopy on optic nerves and corresponding …
[HTML][HTML] Age-and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia
The global COVID-19 pandemic caused by SARS-CoV-2 predominantly affects the elderly.
Differential expression of SARS-CoV-2 entry genes may underlie the variable susceptibility in …
Differential expression of SARS-CoV-2 entry genes may underlie the variable susceptibility in …
Treatment with the dual-incretin agonist DA-CH5 demonstrates potent therapeutic effect in a rat model of Wolfram Syndrome
Aim Wolfram Syndrome (WS) is a rare condition caused by mutations in Wfs1, with a poor
prognosis and no cure. Mono-agonists targeting the incretin glucagon-like-peptide 1 (GLP-1) …
prognosis and no cure. Mono-agonists targeting the incretin glucagon-like-peptide 1 (GLP-1) …
[PDF][PDF] The Sino-Nasal Outcome Test-22: translation and validation in an Estonian population
M Plaas, P Kasenõmm - Rhinology online, 2019 - pdfs.semanticscholar.org
Background: Background: The Sino-Nasal Outcome Test-22 (SNOT-22) is widely used to
assess symptom severity and quality of life for chronic rhinosinusitis patients. No translated …
assess symptom severity and quality of life for chronic rhinosinusitis patients. No translated …
Rinosinusiidi diagnostika ja ravi–ülevaade ravijuhenditest ja konsensusdokumentidest
M Plaas, P Kasenõmm - Eesti Arst, 2017 - ojs.utlib.ee
Rinosinusiit on nina ja ninakõrvalurgete põletik. Haigus jagatakse sümptomite kestuse järgi
ägedaks (sümptomid vähem kui 12 nädalat) ja krooniliseks (sümptomid üle 12 nädala) …
ägedaks (sümptomid vähem kui 12 nädalat) ja krooniliseks (sümptomid üle 12 nädala) …
Kroonilise rinosinusiidi bioloogiline ravi
S Salben, M Plaas - Eesti Arst, 2019 - ojs.utlib.ee
Krooniline rinosinusiit on nina ja ninakõrvalkoobaste põletik kestusega üle 12 nädala. See
haigus mõjutab sageda esinemise tõttu paljude elukvaliteeti ja põhjustab kulusid …
haigus mõjutab sageda esinemise tõttu paljude elukvaliteeti ja põhjustab kulusid …
Krooniline sinusiit tsüstilise fibroosi korral haigusjuhu näitel
M Plaas - Eesti Arst, 2018 - ojs.utlib.ee
Tsüstiline fibroos (TF) on autosoom-retsessiivselt päritav haigus, mis põhjustab tihkete
sekreetide teket kogu kehas. TFi korral esineb sagedasti, peaaegu 100%-l juhtudest krooniline …
sekreetide teket kogu kehas. TFi korral esineb sagedasti, peaaegu 100%-l juhtudest krooniline …
Bovine Colostrum Derived Antibodies Against SARS-CoV-2 Show Great Potential to Serve as a Prophylactic Agent (preprint)
Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) until now imposes a serious
burden to health systems globally. Despite worldwide vaccination, social distancing and …
burden to health systems globally. Despite worldwide vaccination, social distancing and …
Age-and airway disease related gene expression patterns of key SARS-CoV-2 entry factors in human nasal epithelia (preprint)
The global COVID-19 pandemic caused by SARS-CoV-2 predominantly affects the elderly.
Differential expression of SARS-CoV-2 entry genes may underlie the variable susceptibility in …
Differential expression of SARS-CoV-2 entry genes may underlie the variable susceptibility in …
